A detailed history of Copia Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Copia Wealth Management holds 302 shares of AMGN stock, worth $89,603. This represents 0.06% of its overall portfolio holdings.

Number of Shares
302
Previous 127 137.8%
Holding current value
$89,603
Previous $35.5 Million 140.34%
% of portfolio
0.06%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$271.18 - $309.22 $47,456 - $54,113
175 Added 137.8%
302 $85.2 Million
Q1 2025

Apr 17, 2025

SELL
$258.59 - $327.36 $11,377 - $14,403
-44 Reduced 25.73%
127 $39.6 Million
Q4 2024

Mar 06, 2025

BUY
$258.78 - $328.31 $44,251 - $56,141
171 New
171 $44.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $159B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Copia Wealth Management Portfolio

Follow Copia Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copia Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Copia Wealth Management with notifications on news.